Healy James's Form 4 filing
Karuna Therapeutics, Inc. (KRTX) · filed Jan 17, 2023
- Accession no.
- 0001104659-23-004364
- Filed
- Jan 17, 2023
- Trade date
- Jan 12-13, 2023
- Filing delay
- 5 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions. Open-market sales total $1.20M. It was filed 5 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Healy JamesCIK 0001245624 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 12, 2023 | Common Stock | JOtherDisposed | −300,000 | $0.00 | $0 | 1,772,441 | Indirect | |
| Jan 12, 2023 | Common Stock | JOtherAcquired | +6,027 | $0.00 | $0 | 6,027 | Indirect | |
| Jan 13, 2023 | Common Stock | SSaleDisposed | −6,027 | $199.90 | −$1,204,797.3 | 0 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.